These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 12181104)
1. Anthropometric and behavioral correlates of insulin-like growth factor I and insulin-like growth factor binding protein 3 in middle-aged Japanese men. Teramukai S; Rohan T; Eguchi H; Oda T; Shinchi K; Kono S Am J Epidemiol; 2002 Aug; 156(4):344-8. PubMed ID: 12181104 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study. Gapstur SM; Kopp P; Chiu BC; Gann PH; Colangelo LA; Liu K Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2208-16. PubMed ID: 15598782 [TBL] [Abstract][Full Text] [Related]
3. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. DeLellis K; Rinaldi S; Kaaks RJ; Kolonel LN; Henderson B; Le Marchand L Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1444-51. PubMed ID: 15342444 [TBL] [Abstract][Full Text] [Related]
4. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands. Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls. Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852 [TBL] [Abstract][Full Text] [Related]
6. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Gram IT; Norat T; Rinaldi S; Dossus L; Lukanova A; Téhard B; Clavel-Chapelon F; van Gils CH; van Noord PA; Peeters PH; Bueno-de-Mesquita HB; Nagel G; Linseisen J; Lahmann PH; Boeing H; Palli D; Sacerdote C; Panico S; Tumino R; Sieri S; Dorronsoro M; Quirós JR; Navarro CA; Barricarte A; Tormo MJ; González CA; Overvad K; Paaske Johnsen S; Olsen A; Tjønneland A; Travis R; Allen N; Bingham S; Khaw KT; Stattin P; Trichopoulou A; Kalapothaki V; Psaltopoulou T; Casagrande C; Riboli E; Kaaks R Int J Obes (Lond); 2006 Nov; 30(11):1623-31. PubMed ID: 16552400 [TBL] [Abstract][Full Text] [Related]
7. Time spent walking or exercising and blood levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3): A large-scale cross-sectional study in the Japan Collaborative Cohort study. Wakai K; Suzuki K; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A; Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():23-7. PubMed ID: 20553077 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study. Szulc P; Joly-Pharaboz MO; Marchand F; Delmas PD Calcif Tissue Int; 2004 Apr; 74(4):322-9. PubMed ID: 15255068 [TBL] [Abstract][Full Text] [Related]
9. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. Benbassat CA; Maki KC; Unterman TG J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538 [TBL] [Abstract][Full Text] [Related]
10. Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender. Faupel-Badger JM; Berrigan D; Ballard-Barbash R; Potischman N Ann Epidemiol; 2009 Dec; 19(12):841-9. PubMed ID: 19944347 [TBL] [Abstract][Full Text] [Related]
11. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status. Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750 [TBL] [Abstract][Full Text] [Related]
12. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Holmes MD; Pollak MN; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):862-7. PubMed ID: 12223430 [TBL] [Abstract][Full Text] [Related]
13. Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women. Sandhu MS; Gibson JM; Heald AH; Dunger DB; Wareham NJ Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):166-70. PubMed ID: 14744751 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. Paolisso G; Ammendola S; Del Buono A; Gambardella A; Riondino M; Tagliamonte MR; Rizzo MR; Carella C; Varricchio M J Clin Endocrinol Metab; 1997 Jul; 82(7):2204-9. PubMed ID: 9215295 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men. Sarma AV; Jaffe CA; Schottenfeld D; Dunn R; Montie JE; Cooney KA; Wei JT Urology; 2002 Mar; 59(3):362-7. PubMed ID: 11880071 [TBL] [Abstract][Full Text] [Related]
16. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Kawachi S; Takeda N; Sasaki A; Kokubo Y; Takami K; Sarui H; Hayashi M; Yamakita N; Yasuda K Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):617-21. PubMed ID: 15625284 [TBL] [Abstract][Full Text] [Related]
17. Serum insulin-like growth factor binding protein-1 levels and bone mineral density in older adults: the Rancho Bernardo Study. Jassal SK; von Muhlen D; Barrett-Connor E; Rosen CJ Osteoporos Int; 2005 Dec; 16(12):1948-54. PubMed ID: 16088361 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men. Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]